Warfarin PharmacogeneticsDr Dyfrig A. Hughes,Munir Pirmohamed · PharmacoEconomics · 2007

Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for goutPlumpton, Catrin O.; Alfirevic, Ana; Pirmohamed, Munir; Hughes, Dyfrig A. · Rheumatology · 2017

A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug ReactionsPlumpton, Catrin O.; Roberts, Daniel; Pirmohamed, Munir; Hughes, Dyfrig A. · PharmacoEconomics · 2016

Cost-effectiveness of screening for <i>HLA-A*31:01</i> prior to initiation of carbamazepine in epilepsyPlumpton, Catrin O.; Yip, Vincent L. M.; Alfirevic, Ana; Marson, Anthony G.; Pirmohamed, Munir; Hughes, Dyfrig A. · Epilepsia · 2015

Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service deliveryPowell, Graham; Holmes, Emily A. F.; Plumpton, Catrin O.; Ring, Adele; Baker, Gus A.; Jacoby, Ann; Pirmohamed, Munir; Marson, Anthony G.; Hughes, Dyfrig A. · British Journal of Clinical Pharmacology · 2015

Better antibiotics through chemistryFrantz, Simon · Nature Reviews Drug Discovery · 2004

Vioxx risk signifies trouble in classFrantz, Simon · Nature Reviews Drug Discovery · 2004

Inherent anticipationBecker, Daniel M. · Nature Reviews Drug Discovery · 2005

Merck and Integra battle onOwens, Joanna · Nature Reviews Drug Discovery · 2005

In BriefFrantz, Simon · Nature Reviews Drug Discovery · 2005

Can making a correlation be patented?Owens, Joanna · Nature Reviews Drug Discovery · 2005

Chronic myelogenous leukaemia marketStorey, Shane · Nature Reviews Drug Discovery · 2009

Neurodegenerative Disease: Rescuing memoryHarrison, Charlotte · Nature Reviews Drug Discovery · 2010